SM SLEEP SOLUTIONS LTD

SM SLEEP SOLUTIONS LTD

Statement of Financial Position

As at 30 June 2026

	£	2026 £
Current assets	1
Creditors: amount falling due within one year	(146)
Net current assets/(liabilities)		(145)
Total assets less current liabilities		(145)
Net assets/(liabilities)		(145)


Capital and reserves		(145)

Notes to the Accounts

Statutory Information

Sm Sleep Solutions Ltd is a private limited company, limited by shares, domiciled in Northern Ireland, registration number NI728643, registration address 29 Tullynahinnion Road, Portglenone, Ballymena, BT44 8EL, Northern Ireland.

The presentation currency is £ sterling.

Accounting Policies

Basis of accounting

The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

Going Concern

The Company has discontinued the operation and the current accounts are the last set of accounts after this the directors are planning to apply for striking off the name from the registrar of the Companies.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.	Average number of employees Average number of employees during the period was 1.

Director's Responsibilities:

For the period ended 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:

---------------------------------------------

Stuart Robert Marks
Director

Date approved: 26 July 2026